Academic Achievements

Fellows Recognition

• Markie Zimmer – Fellow Member at MSHO Board of Directors 2024-present
• Markie Zimmer – Recipient of 2026 Conquer Cancer Merit Award, ASCO
• Markie Zimmer – Recipient of First Place Award at the 2026 Annual Hematology Jeopardy Competition, MSHO
• Markie Zimmer – Member at ASH Medical Educators Institute, American Society of Hematology
• Bipin Ghimrie - Recipient of First Place Award at the 2026 Annual Hematology Jeopardy Competition, MSHO
• Linda Albusoul - Selected for the 2026 Next Wave Forum for Young Investigators Workshop

Publications

Nasser Z, Tahmazian S, Srinivasan S, Gutta R, Ghosh S, Abu Rous F. Immunotherapy in combination with chemotherapy as first-line treatment in NUT carcinoma. Manuscript submitted to Journal of Thoracic Oncology Clinical and Research Reports. June 2026.

Albusoul L, Welch L, Margolis M, Al Saheli Z, Khan G, Philip P, Diab M. Real-world Outcomes in Gastrointestinal Cancer Patients with Targetable Genomic Alterations Identified on Serial Liquid Biopsy. J Clin Oncol 44, 2026 (supp 16; abstr 4238).

A. T. Skowron, K. Childers, C. M. Rose, K. C. McElyea, et al., “Socioeconomic and Demographic Factors in Genetic Testing Utilization Among Advanced Prostate Cancer Patients,” Prostate86 (2026): 941-948

K. C. McElyea, J. P. Purtell, A. K. Supernois, et al., “Genetic Testing Among Black and White Patients With Advanced Prostate Cancer: A Retrospective Analysis of Testing Utilization and Referral Patterns,” The Prostate86 (2026): 440-450

Nasser Z, Tahmazian S, Bughrara M, Nasser B, Ramo A, Dabak V. A Rare Presentation of T-cell Prolymphocytic Leukemia With Abnormal Uterine Bleeding. J Hematol. 2026 Jan 4;15(1):45-49. doi: 10.14740/jh2152. PMID: 41768867; PMCID: PMC12948471.

Abad J, Khaliq I, Zimmer M, Kuriakose P. Old Dominion, New Problem: A rare cause of undetectable HbA1c. Poster presented at: Henry Ford Health Medical Education Research Forum; Detroit, MI; April 24, 2026.

Kyle McElyea, Abdel-Azez Abu-Samak, Vijaya Donthireddy, et al. Assessing and enhancing nurse-physician communication in the infusion center to improve patient care.. JCO Oncol Pract 21, 78-78(2025)

Ramalingam P, Nasser Z, Patel K, Dabak V. Piperacillin-Tazobactam Strikes Again: A Neutropenic Mystery Unraveled. Cureus. 2025 Sep 25;17(9):e93189. doi: 10.7759/cureus.93189. PMID: 41141127; PMCID: PMC12553395.

Ghimire B, Zimmer M, Donthireddy V. TP53 mutated acute myeloid leukemia: review of treatment and challenges. Eur J Haematol. 2025;114:924-937.

Zimmer M, Abad J, Gupta J, Ghosh S, Kuriakose P. Secondary hematologic malignancies in patients previously treated for multiple myeloma: evaluating the impact of patient race in an urban setting. Clinical Lymphoma, Myeloma & Leukemia. 2025;25:S919. Poster presented at: SOHO Annual Meeting; Houston, TX; September 3-6, 2025.

Zimmer M, Jacob B, Spica M, Ghosh S, Dabak V. Outcomes of acute myeloid leukemia treated with a hypomethylating agent and venetoclax. Cancer Res. 2025;85(8 Suppl 1):5960. Poster presented at: AACR Annual Meeting; Chicago, IL; April 25-30, 2025.